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Abstract
Background: Many patients suffering acute myocardial infarction (AMI) are transferred from one
hospital to another during their hospitalization. There is little information about the outcomes
related to interhospital transfer. The purpose of this study was to compare processes and
outcomes of AMI care among patients undergoing interhospital transfer with special attention to
the impact on mortality in rural hospitals.
Methods: National sample of Medicare patients in the Cooperative Cardiovascular Study (n =
184,295). Retrospective structured medical record review of AMI hospitalizations. Descriptive
study using a retrospective propensity score analysis of clinical and administrative data for 184,295
Medicare patients admitted with clinically confirmed AMI to 4,765 hospitals between February
1994 and July 1995. Main outcome measure included: 30-day mortality, administration of aspirin,
beta-blockers, ACE-inhibitors, and thrombolytic therapy.
Results: Overall, 51,530 (28%) patients underwent interhospital transfer. Transferred patients
were significantly younger, less critically ill, and had lower comorbidity than non-transferred
patients. After propensity-matching, patients who underwent interhospital transfer had better
quality of care anlower mortality than non-transferred patients. Patients cared for in a rural hospital
had similar mortality as patients cared for in an urban hospital.
Conclusion: Transferred patients were vastly different than non-transferred patients. However,
even after a rigorous propensity-score analysis, transferred patients had lower mortality than non-
transferred patients. Mortality was similar in rural and urban hospitals. Identifying patients who
derive the greatest benefit from transfer may help physicians faced with the complex decision of
whether to transfer a patient suffering an acute MI.
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Background
Ischemic heart disease is the leading cause of death world-
wide, causing 6.26 million deaths per year[1]. Acute myo-
cardial infarction (AMI) is a major cause of death in the
United States, accounting for 203,551 deaths in 1998[2].
A growing number of AMI patients are transferred from
one hospital to another during their hospital course[3,4].
While there is nothing intrinsically beneficial about mov-
ing a patient from one hospital to another, transfer may
provide the opportunity for higher level of care and more
advanced treatment. Several observational studies on gen-
eral medical and surgical patients reported that trans-
ferred patients, regardless of their diagnosis, were sicker,
had more co-morbid conditions, used more resources,
required longer hospital stays, and had higher mortality
[5-7]. Another study found that transferred patients had
less severe illness and lower mortality[8]. Factors that
might confound these previous findings include changing
economic motivation for transfer, greater variation in
availability of advanced technology, and widespread
attempts to improve quality of care [3,9].
Early studies on myocardial infarction called for the trans-
fer of "high risk patients"[10]. The conventional wisdom
was to transfer the sickest cardiac patients or patients who
had failed less invasive therapy to the tertiary care hospital
for specialized care [11-14]. However, several more recent
studies found that transferred acute MI patients were
younger and had fewer comorbid conditions[4,15]. Rural
MI patients are more likely to be transferred, however,
rural patients have also been reported to receive lower
quality of care[16]. Many studies on acute MI have deleted
some or all transferred patients from their analysis [17-
19].
The impact of interhospital transfer on processes and out-
comes of acute MI has largely gone unstudied. Because the
number of AMI patients undergoing interhospital transfer
is rising we examined the impact of interhospital transfer
on mortality. We used data from the Cooperative Cardio-
vascular Project (CCP), a large and representative sample
with detailed clinical and quality of care information on
patients hospitalized with AMI.
Methods
Cardiovascular Cooperative Project
The CCP was a national quality improvement project
sponsored by the Centers for Medicare and Medicaid Serv-
ices (CMS), formerly the Health Care Financing Adminis-
tration for Medicare patients hospitalized with
AMI[20,21]. Patients were initially identified from Medi-
care claims data using the principal diagnosis code of 410
from International Classification of Diseases, Ninth Revi-
sion, Clinical Modification[22]. The CCP performed
structured medical record review for 234,769 Medicare fee
for service patients randomly sampled from 6,684 hospi-
tals in all 50 states who were hospitalized for AMI
between February 1994 and July 1995. As a quality check,
an independent abstraction for a randomly selected 5% of
the charts was done to assess reliability and validity for
key variables. The methods of the CCP are fully described
elsewhere[20,21].
Patients
Patients were excluded from our analyses for: 1) lack of
clinically confirmed AMI according to criteria established
by Ellerbeck[21] (n = 31,194); 2) admission to hospital
with unclear teaching status, technology index, or rural/
urban status (n = 262); 3) age less than 65 years (n =
15,072); and 5) death on day of admission for patients
who were not transferred (n = 3,946). Patients who died
on the day of admission were excluded because they had
less opportunity for transfer. Application of these exclu-
sions left 184,295 patients from 4,765 hospitals.
Patients who underwent transfer were our primary study
group of interest. We define "transfer" as occurring when
a patient is admitted to one acute care hospital and dis-
charged from a different hospital during an episode of
care for an AMI. The CCP records for patients transferred
into an index hospital contain the source of admission
but no detailed information on pre-admission clinical
course. For patients transferred from an index hospital,
the records contain discharge destination but not detailed
information on post-discharge course. However, vital sta-
tus was available for all patients from Medicare adminis-
trative data, in particular at 30 days after hospitalization.
Hospitals
Teaching hospitals were defined as those with an intern/
bed ratio greater than zero[8], as assessed by merging the
CCP and CMS administrative data sets. Hospital location
was defined as rural or urban by metropolitan statistical
area[23].
For each hospital, we derived a technology index (TI) as
described below:
1. No Angiographic, PTCA or CABG capacity
2. Angiographic capacity only
3. Angiographic and PTCA capacity only
4. Angiographic, PTCA, and CABG capacity
Process and outcome measures
We focused on four quality measures that were developed
as part of the CCP: in-hospital administration of aspirin,BMC Cardiovascular Disorders 2008, 8:22 http://www.biomedcentral.com/1471-2261/8/22
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beta-blockers, ACE- inhibitors and acute reperfusion to
eligible candidates. We considered beta-blockers indi-
cated for those patients who both lacked absolute con-
traindications and met inclusion criteria[20]. We
considered aspirin and thrombolytic therapy indicated in
patients who lacked both absolute and relative contrain-
dications and met inclusion criteria. Definitions of con-
traindications and therapy groups are described further in
Allison et al[24]. Because of significant interactions
between receipt of acute reperfusion and aspirin, we cre-
ated 5 mutually exclusive groups of patients: therapy cat-
egory 0, those who received no therapy (reference group);
therapy category 1, those who received no aspirin and no
reperfusion but did receive angiotensin-converting
enzyme (ACE) inhibitors and/or b-blockers; therapy cate-
gory 2, those who received no reperfusion but did receive
aspirin and/or ACE inhibitors and/or b-blockers; therapy
category 3, those who received no aspirin but did receive
reperfusion and/or ACE inhibitors and/or b-blockers; and
therapy category 4, those who received aspirin and reper-
fusion and/or ACE inhibitors and/or b-blockers.
Patients transferred in from another acute care hospital
were not considered eligible for reperfusion at the receiv-
ing hospital. Mortality at 30 days after admission was
ascertained from HCFA administrative data. Patient co-
morbidity and severity of illness were assessed by the
Adapted Charlson Index[25] and by the APACHE II
scale[26], respectively.
Statistical analyses
Two separate analyses were conducted. First, we compared
transferred and non-transferred patients. Because inter-
hospital transfer is more common in rural hospitals we
performed a second analysis comparing patients cared for
in rural and urban hospitals. Differences between groups
(transferred v non-transferred and rural v urban) were
tested using the chi-square or Kruskal-Wallis test[27].
We first examined unadjusted 30-day mortality for each
comparison group; transfer v non-transfer, and rural v
urban. Predicted mortality was calculated using patient
demographics, and other clinical predictors of mortality
based on the work of Krumholz (age, gender, race, serum
white blood count [WBC] on admission, serum creati-
nine, presence of heart failure on admission, cardiac
arrest, and location of MI)[28].
Because transfer status and location of hospital was not
randomly assigned in this patient population, there was
substantial potential for confounding and selection bias.
We chose to account for this by developing a propensity
score for transfer and rural status. Propensity score analy-
sis is a post-hoc statistical method that estimates treat-
ment effect when subjects were not randomly assigned to
treatment group. Propensity score analysis attempts to
simultaneously control for all known patient factors that
might be related to the outcome of interest. Joffe and
Rosenbaum have described the rationale and methods
underlying the use of propensity score analysis[29].
We constructed nonparsimonious logistic regression
models in which inter-hospital transfer was a dependent
variable and the variables in Table 1 were independent
variables. These models made it possible to calculate a
propensity score, indicating the likelihood that any indi-
vidual patient would undergo interhospital transfer given
all other known variables except 30-day mortality. The C-
statistic of the logistic regression model used to generate
the propensity score for transfer was 0.68 indicating a
moderate ability to differentiate between transferred and
non-transferred patients. The C-statistic represents the dis-
criminative power of the logistic regression model. We
performed a similar analysis for patients cared for in a
rural hospital. The C-statistic of the logistic regression
model used to generate the propensity score for rural hos-
pital status was 0.57 indicating a fair ability to differenti-
ate between rural and urban patients.
We used the propensity score to randomly match trans-
ferred patients to non-transferred patients and rural
patients to urban patients. Specifically, pairs of propensity
scores were randomly matched using a greedy matching
technique[30]. This technique randomly matched 44,175
transferred and non-transferred patients and 32,131 rural
and urban patients.
For each comparison we then used a multivariable logistic
regression model to adjust mortality analyses for patient
demographics, severity of illness based on work by Krum-
holz[28], treatment according to a schema developed by
Allison[24], hospital technology index, teaching status,
and hospital size. We included in each analysis any addi-
tional covariant for which there had been a significant dif-
ference among our propensity-matched cohorts. All
analyses were conducted using SAS version 9.00 (SAS
Institute Inc., Cary, NC).
Results
Hospital and patient characteristics
Our study sample consisted of 184,295 patients from
4,765 hospitals. Overall, 51,530 AMI patients (28.0%)
were transferred at some point during their hospital stay;
32,080 (17.4%) were transferred out of and 19,450
(10.6%) transferred into a CCP hospital. 35,824 (19.4%)
patients were cared for in a rural hospital. Rural hospitals
transferred 33.8% while urban hospitals only transferred
26.6%. Hospitals with lower technology index transferred
a higher proportion of their patients (34% for low tech-
nology hospitals v 23% or high technology hospitals).BMC Cardiovascular Disorders 2008, 8:22 http://www.biomedcentral.com/1471-2261/8/22
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Baseline patient characteristics according to transfer status
and hospital location are summarized in Table 1. Because
the CCP is such a large database there are statistically sig-
nificant differences that do not necessarily represent clin-
ically significant differences. It is essential to consider
both clinical and statistical significance when reviewing
these tables. Table 2 describes treatment and crude mor-
tality rates.
Transfer and mortality
Transferred patients were younger and had much lower
predicted mortality than non-transferred patients. Trans-
ferred patients were more likely to be male, less likely to
be African American, and less likely to have diabetes and
a history of heart failure. Transferred patients were less
likely to have heart failure or an abnormal heart rhythm
on admission. Transferred patients had higher rates of use
for of aspirin, beta-blockers, and thrombolytics (Table 2).
30,586 (16.6%) patients died within 30 days. Unadjusted
30-day mortality was lower among transferred patients
(10.7% v 18.9%, p < .001). Based on systematically col-
lected data for baseline demographics and medical risk
factors a logistic regression model was used to generate a
propensity score for transfer. The baseline demographic
and medical risks comparing propensity matched trans-
ferred and non-transferred patients are shown in Table 3.
As opposed to the entire population of CCP patients,
these propensity-matched patients were well matched; the
only clinically significant differences were that transferred
patients had a slightly higher predicted mortality (15% v
14%, p = .007) and a slightly lower rate of diabetes
Table 1: Patient characteristics for transferred v non-transferred patients and rural v urban patients*
Non-Transferred
N = 132,765
Transferred
N = 51,530
Urban
N = 148,471
Rural
N = 35,824
Continuous Variables
Mean Mean p-value Mean Mean p-value
Age 77.2 73.5 < 0.001 76.0 76.7 < 0.001
Charlson Score 0.72 0.55 < 0.001 0.67 0.68 0.06
Krumholz Predicted Mortality 0.19 0.15 < 0.001 0.18 0.18 0.07
APACHE Score 9.9 8.2 < 0.001 9.4 9.6 < 0.001
SBP on Admittance 144 141 < 0.001 142 146 < 0.001
Creatinine on Admission 1.4 1.3 < 0.001 1.4 1.4 0.12
WBC on Admission 11.0 10.6 < 0.001 10.9 10.8 < 0.001
Categorical Variables
% % p-value % % p-value
Female 50 44 < 0.001 48 49 <0.001
African American 6 4 < 0.001 6 5 < 0.001
Terminal Illness 0.4 0.2 < 0.001 0.4 0.4 0.76
Diabetes 31 29 < 0.001 31 31 0.77
Chronic Renal Insufficiency 5 3 < 0.001 5 4 < 0.001
Hypertension 62 61 < 0.001 63 59 < 0.001
Malignancy 3 2 < 0.001 3 3 0.63
History of Heart Failure 24 13 < 0.001 21 22 < 0.001
History of CAD 40 36 < 0.001 39 37 < 0.001
History of Acute MI 32 28 < 0.001 31 31 0.08
History of PCTA 7 9 < 0.001 8 5 < 0.001
History of Bypass Surgery 13 12 < 0.001 13 11 < 0.001
Shock on Admittance 5 4 < 0.001 5 3 < 0.001
Cardiac Arrest 15 12 < 0.001 14 16 < 0.001
Heart Failure on Admission 51 37 < 0.001 48 46 < 0.001
Angina on Admission 2 3 < 0.001 2 3 < 0.001
Abnormal Rhythm on Admission 49 42 < 0.001 47 44 < 0.001
Anterior or Lateral MI 47 46 0.40 47 46 < 0.001
*Because the CCP includes such a large number of subjects, there are statistically significant differences that do not necessarily represent clinically 
significant differences.BMC Cardiovascular Disorders 2008, 8:22 http://www.biomedcentral.com/1471-2261/8/22
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(29.5% v 30.3%, p = .009). Transferred patients had a
lower unadjusted 30-day mortality (10.7% v 12.5%. p <
.001). This mortality advantage persisted after adjustment
for patient demographics, therapy, and hospital character-
istics. (O.R. for 30-day mortality = 0.80, 95% C.I. 0.76–
0.84) (Table 4).
Rural hospital and mortality
35,824 (19.4%) patients were cared for in a rural hospital.
Rural patients were slightly older than urban patients, but
had similar predicted mortality (Table 1). Rural patients
were more likely to be female, less likely to be African
American, had a higher rate of history of heart failure but
had similar rates of diabetes. Rural patients were slightly
less likely to have heart failure or an abnormal heart
rhythm on admission. Rural patients had lower rates of
use for aspirin, beta-blockers, and ACE-Inhibitors, but a
higher rate of use for thrombolytic therapy (Table 2).
The baseline demographic and medical risks among pro-
pensity matched rural and urban patients are shown in
Table 3. These propensity-matched patients were well
matched. Rural patients had a higher unadjusted 30-day
mortality (17.5% v 16.3%. p < .001). However, after
adjustment for patient demographics, therapy, and hospi-
tal characteristics this mortality advantage disappeared.
(O.R for 30-day mortality = 1.05, 95% C.I. 0.99–1.11)
(Table 4).
Discussion
We found that over one quarter of AMI patients were
transferred during their hospital course. Transferred
patients were significantly younger and more often white,
male, with fewer co-morbid conditions and less severe
disease. Transferred patients were also more likely to
receive appropriate therapy. Transferred patients had
lower unadjusted 30-day mortality than non-transferred
patients. After a rigorous propensity analysis of nearly
90,000 propensity -matched patients, this mortality bene-
fit persisted. Physicians decide to transfer patients for
many explicit and implicit reasons. The transferring phy-
sicians in the CCP may have understood which patients
would most benefit from transfer. Testing these hypothe-
ses will require prospective data collected with more clin-
ical detail than we have available in the current data.
We found that patients cared for in rural hospitals had
slightly lower rates of treatment with 3 quality care meas-
ures (aspirin, beta-blockers, and ACE-Inhibitors), while
they had a higher rate of treatment with thrombolytic
therapy. This may be due to decreased availability of angi-
oplasty in rural hospitals. After analysis of over 64,000
propensity-matched patients and adjustment for patient
differences, treatment differences and hospital character-
istics, patients cared for in a rural hospital had similar
mortality as patients cared for in an urban hospital. The
high rate of transfer among younger, healthier patients
may partially account for the lower quality of care and
worse outcomes ascribed to rural hospitals previously
reported by others.
To our knowledge, this is the first national study of the
characteristics and mortality of Medicare patients with
AMI according to transfer status. Our results are consistent
with those of Mehta and colleagues, who used CCP data
only from the state of Michigan to examine the implica-
tions of patient transfer[15]. Mehta found that patients
who were transferred from hospitals with lower techno-
Table 2: Treatment and crude mortality among transferred v non-transferred patients and rural v urban patients
Non-Transferred
N = 132,765
Transferred
N = 51,530
Urban
N = 148,471
Rural
N = 35,824
Continuous Variables
Mean Mean p-value Mean Mean p-value
Length of Stay 8.2 5.9 < 0.001 7.9 5.9 < 0.001
Categorical Variables
%% % %
ASA if Eligible 84 89 < 0.001 87 82 < 0.001
Beta Blocker if Eligible 50 57 < 0.001 54 44 < 0.001
ACE-I if Eligible 33 21 < 0.001 31 28 < 0.001
Thrombolytics if Eligible 53 71 < 0.001 58 62 < 0.001
Tobacco Cessation Counseling 6 6 0.02 6 5 < 0.001
Died Within 30 Days 19 11 < 0.001 16 18 < 0.001BMC Cardiovascular Disorders 2008, 8:22 http://www.biomedcentral.com/1471-2261/8/22
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logical capability to hospitals with higher technological
capability tended to be younger, more likely to be white
and male, and had lower predicted mortality.
The bulk of the literature on transfer of patients with AMI
focuses exclusively on patients transferred for specific pro-
cedures [31-34]. For example, Straumann et al. evaluated
prospectively the baseline characteristics and outcomes of
AMI patients transferred to a tertiary referral center for pri-
mary PTCA and compared these patients with patients
directly admitted to the same referral center[35]. They
found that the patients who were transferred-in tended to
be younger, more critically ill, more likely to be in cardio-
genic shock or require resuscitation, but had similar mor-
tality. Liem et al. compared transferred to non-transferred
PTCA patients to evaluate treatment delay, infarct size and
mortality[36]. They found that despite an average 43-
minute treatment delay for transfers and larger infarct
size, transferred and non-transferred patients had similar
6-month clinical outcomes. Andersen et al. recently
reported that patients transferred for primary PTCA had
better outcomes than non-transferred patients receiving
thrombolytic therapy[37]. However, the benefit was
solely in terms of decreased re-infarction and there was no
statistically significant benefit to transfer in terms of mor-
tality or stroke.
Our finding that there are major differences between
transferred and non-transferred patients has particular rel-
evance for the understanding of quality of care in rural
hospitals. Previous studies have frequently deleted trans-
ferred patients from analysis. Because transferred patients
tend to be younger, healthier, male, and have lower pre-
dicted mortality, comparisons between hospitals are sub-
ject to a significant bias against hospitals that transfer a
higher proportion of AMI patients. Thiemann and Casale
in separate reports found that rural and smaller hospitals
had worse outcomes than urban and larger hospi-
Table 3: Patient characteristics according to transfer status and hospital location in propensity matched groups
Non-Transferred
N = 44,175
Transferred
N = 44,175
Urban
N = 32,131
Rural
N = 32,131
Continuous Variables
Mean Mean p-value Mean Mean p-value
Age 73.4 73.5 0.13 76.6 76.7 0.63
Charlson Score 0.56 0.55 0.17 0.68 0.68 0.59
Krumholz Predicted Mortality 0.14 0.15 <.01 0.18 0.18 0.60
APACHE Score 8.4 8.4 0.52 9.6 9.6 0.61
SBP on Admission 143 142 0.02 147 146 0.50
Creatinine on Admission 1.27 1.28 0.09 1.4 1.4 0.84
WBC on Admission 10.6 10.6 0.83 10.8 10.8 0.53
Categorical Variables
% % p-value % % p-value
Female 43 43 0.39 49 49 0.89
African American 4 4 0.24 5 5 0.83
Terminal Illness 0.2 0.2 0.83 0.3 0.4 0.89
Diabetes 30 29 <.01 31 31 0.73
Chronic Renal Insufficiency 3 3 0.77 4 4 0.93
Hypertension 61 61 0.59 59 59 0.67
Malignancy 2 2 0.79 3 3 0.05
History of Heart Failure 13 13 0.08 23 23 0.36
History of CAD 37 36 0.07 38 37 0.39
History of Acute MI 28 28 0.95 31 31 0.28
History of PCTA 9 8 0.33 5 5 0.91
History of Bypass Surgery 13 12 <.01 11 11 0.38
Shock on Admission 4 4 0.14 3 3 1.00
Cardiac Arrest 13 12 0.01 15 15 0.10
Heart Failure on Admission 38 38 0.90 46 46 0.98
Angina on Admission 3 3 0.06 3 3 0.73
Abnormal Rhythm on Admission 42 41 0.18 44 44 0.67
Anterior or Lateral MI 47 47 0.85 46 46 0.59BMC Cardiovascular Disorders 2008, 8:22 http://www.biomedcentral.com/1471-2261/8/22
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tals[16,17]. However, their studies deleted transferred
patients from their analysis. After accounting for the
numerous and large differences between transferred and
non-transferred patients, we found that patients cared for
in rural hospitals had similar outcomes to patients cared
for in urban hospitals.
Although the reason for transfer is not documented in the
CCP dataset, we can make some inferences based on the
characteristics of hospitals transferring and accepting
patients, and by the treatments administered to each
group of patients. From our data it is clear that smaller,
rural hospitals with less technological capacity are more
likely to transfer patients to another institution. Larger,
urban hospitals with the ability to perform cardiac cathe-
terization, PTCA, and bypass surgery are less likely to
transfer.
In a rural hospital without advanced cardiac services
transfer may be viewed as a treatment option, just like the
use of aspirin, beta-blockers, and thrombolytics. While
there are evidence-based guidelines for the medical treat-
ments of acute MI, there are no guidelines aiding the deci-
sion of whether to transfer a patient suffering an acute MI.
Certainly, a patient who requires cardiac surgery or urgent
angiography will benefit from transfer. Identification of
other patient groups likely to benefit from transfer will
provide guidance to the clinician faced with the decision
whether or not to transfer a patient.
For health services research the issue surrounding the
analysis of transferred patients is complex. There is disa-
greement about where to assign responsibility for out-
comes. Because transfer is so common and may actually
represent a treatment option, rather than an outcome, the
"assignment of responsibility" may not be the most
important question. The important question for hospitals
without interventional cardiac services may be how to
identify the patient who is most likely to benefit from
transfer. Transfer rates have increased dramatically in the
past decade making it even more important to understand
the risks and benefits associated with transfer[4].
The major limitation of this study is that transfer and rural
hospitalization were not randomly assigned. The use of
observational studies to assess treatment effects and out-
comes is controversial. Additionally, chart review has its
own unique limitations[38]. Several recent publications
point out that properly performed observational studies
are unlikely to lead to misleading or inappropriate con-
clusions[38,39]. We performed propensity analysis that
provided a robust adjustment for selection bias and con-
founding. However, propensity analysis can only adjust
for measured variables. For example, the CCP does not
Table 4: Odds ratios for 30-day mortality in propensity score matched patients across model groups
Transferred v Non-Transferred (Referent) Rural v Urban (Referent)
O.R. 95% C.I. O.R. 95% C.I.
Assigned Model Covariates
Model Groups (vs Referrent) 0.80 0.76 0.84 1.05 0.99 1.11
Age 1.38 1.35 1.41 1.43 1.39 1.47
Ethnicity (African American as Referent) 0.89 0.79 1.01 0.87 0.77 0.98
Gender (Female as Referent) 1.14 1.09 1.20 1.12 1.07 1.18
Cardiac Arrest 6.66 6.33 7.02 6.23 5.91 6.58
Congestive Heart Failure 2.14 2.04 2.25 2.01 1.91 2.11
Systolic Blood Pressure on Admission 0.71 0.69 0.73 0.66 0.65 0.68
Serum Creatinine on Admission 1.20 1.18 1.22 1.23 1.20 1.26
White Blood Cell Count on Admission 1.26 1.24 1.29 1.25 1.22 1.28
Anterior or Lateral MI 1.49 1.42 1.56 1.51 1.44 1.58
Therapy (1 vs 0) 0.44 0.40 0.49 0.45 0.41 0.49
Therapy (2 vs 0) 0.29 0.27 0.32 0.30 0.28 0.33
Therapy (3 vs 0) 0.72 0.63 0.84 0.65 0.55 0.78
Therapy (4 vs 0) 0.24 0.22 0.26 0.25 0.23 0.28
Technology (1 vs 0) 0.98 0.92 1.05 1.06 0.99 1.13
Technology (2 vs 0) 0.99 0.85 1.15 1.17 0.99 1.37
Technology (3 vs 0) 0.91 0.84 0.98 1.02 0.94 1.11
Hospital Bed Size 0.99 0.97 1.03 0.99 0.95 1.02
Teaching Hospital (vs Non-Teaching) 0.89 0.83 0.94 0.93 0.87 0.99
C-Statistic 0.82 0.82
O.R. for Age, SBP, Serum Creatinine, WBC, and Hospital Bed Size represent 1 standard deviation unit.
O.R. refers to Odds Ratio
C.I. refers to Confidence IntervalBMC Cardiovascular Disorders 2008, 8:22 http://www.biomedcentral.com/1471-2261/8/22
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collect data on socioeconomic factors that may be related
to use of more invasive treatment[40] and may predispose
patients to transfer as well as to improved survival. Due to
missing data we were unable to match a small portion of
the transferred and rural patients. However, our match
rate of 86–90% is within the range of previously reported
propensity analyses[41,42].
Conclusion
We found that Medicare patients that underwent interhos-
pital transfer during care of their acute MI had generally
higher quality of care and lower mortality than non-trans-
ferred patients. However transferred patients were very
different than non-transferred patients. These differences
may partially account for the difference in mortality
between rural and urban hospital previously reported. We
found no difference in 30-day mortality between patients
cared for in a rural or urban hospital. Deleting transferred
patients from analysis may introduce significant bias. For
patients living in a rural community it is reasonable for
them to present to their local hospital, and the decision
whether to transfer or not becomes a clinically important
element in their care. Additional work is needed to better
define characteristics of the patient and the health care
system that might identify those most likely to benefit
from transfer and methods to expedite transfer for those
patients.
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